Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Safer intravenous infusion therapy enabled by aerosol jet printed non-contact ultrasensitive flow sensors

Project description

Smart monitoring of intravenous infusions

Intravenous infusion (IV) is one of the most common hospital procedures worldwide, with over a billion administrations each year. However, incorrect flow rates occur in up to 60 % of cases, posing serious risks for vulnerable patients such as preterm infants and those who are critically ill. Improving accuracy and safety is therefore a pressing clinical need. The ERC-funded iVSEAL project introduces breakthrough technology for monitoring IV flow rates. The system is based on aerosol jet printed micro-electromechanical systems (MEMS) sensors. These sensors are manufactured with high-precision printing and combine electronics and microscopic mechanical parts, allowing them to measure IV flow rates in real time.

Objective

Intravenous (IV) infusion therapy is a widely used procedure in hospitals, with over a billion infusions administered annually globally. Despite its prevalence, IV infusions pose significant risks, with up to 60% experiencing incorrect flow rates, leading to adverse events for vulnerable patient groups such as preterm babies and critically ill individuals. To solve this problem, we developed a patented innovative aerosol jet printed micro-electromechanical-systems (MEMS) flow monitoring technology that measures IV flow rates in real-time and alerts clinicians instantly when a flow discrepancy is detected. The technology stands apart from its competitors due to its accuracy in measuring true flows, compact size, exceptional sensitivity, and cost-effectiveness, heralding a new era in IV patient safety protocols. Through the iVSEAL project, we propose to use these printed MEMS flow sensors in IV infusion monitoring by developing them into a fully-functional medical device (‘works-like’ prototype). Technical validation of the flow monitoring system will involve rigorous in-vitro testing in diverse critical infusion fluids. In addition to technical and pre-clinical validation studies, we will also conduct interviews with the customers, stake-holders and understand the regulatory pathways, and create a business plan.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

RIJKSUNIVERSITEIT GRONINGEN
Net EU contribution
€ 150 000,00
Address
Broerstraat 5
9712CP Groningen
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)